ABSTRACT
Mast cells play a central role in inflammatory and allergic reactions by releasing inflammatory mediators through 2 main pathways, immunoglobulin E-dependent and E-independent activation. In the latter pathway, mast cells are activated by a diverse range of basic molecules (collectively known as basic secretagogues) through Mas-related G protein-coupled receptors (MRGPRs). In addition to the known basic secretagogues, here, we discovered several endogenous protein and enzyme fragments (such as chaperonin-10 fragment) that act as bioactive peptides and induce immunoglobulin E-independent mast cell activation via MRGPRX2 (previously known as MrgX2), leading to the degranulation of mast cells. We discuss the possibility that MRGPRX2 responds various as-yet-unidentified endogenous ligands that have specific characteristics, and propose that MRGPRX2 plays an important role in regulating inflammatory responses to endogenous harmful stimuli, such as protein breakdown products released from damaged or dying cells.
Subject(s)
Cell Degranulation/immunology , Immunoglobulin E/immunology , Mast Cells/immunology , Nerve Tissue Proteins/immunology , Peptide Fragments/immunology , Receptors, G-Protein-Coupled/immunology , Receptors, Neuropeptide/immunology , Animals , Cell Line, Tumor , Chaperonin 10/immunology , HEK293 Cells , Humans , Mast Cells/metabolism , Nerve Tissue Proteins/genetics , PC12 Cells , Rats , Receptors, G-Protein-Coupled/genetics , Receptors, Neuropeptide/genetics , SwineABSTRACT
The human MAS-related G protein-coupled receptor X1 (MRGPRX1) is a member of the GPCR family. The receptor is primate specific and expressed in the sensory neurons of dorsal root ganglion and trigeminal ganglion, where it is considered to be involved in the pain perception. The MRGPRX1 has unusual binding mechanism, as it is activated by several different ligands as well as several different fragments of precursor proteins. Thus, we hypothesize that it is activated by several unknown compounds as well since the receptor is still classified as orphan. Here, we describe the isolation of two novel endogenous ligands for the MRGPRX1 from human platelet preparation. The isolated ligands are hemoglobin ß-chain fragments, known members of the hemorphin family.
Subject(s)
Hemoglobins/metabolism , Peptide Fragments/metabolism , Receptors, G-Protein-Coupled/metabolism , Blood Platelets/metabolism , HumansABSTRACT
BACKGROUND: Mast cells are important modulators of the human immune system via their release of several inflammatory mediators and proteases. The release can be activated by different pathways: the classical immunoglobulin E-dependent pathway and by the non-immunological immunoglobulin E-independent pathway. MAS-related G protein-coupled receptor X2 (MRGPRX2) is expressed in mast cells and it is one of the endogenous receptor responsible for the IgE-independent activation of human mast cell. The MRGPRX2 is classified as orphan receptor and unlike most GPCRs, the MRGPRX2 recognizes a wide range of basic molecules. Thus, there still might be several unknown ligands for the receptor. METHODS: MRGPRX2 activating peptides were isolated from human plasma using consecutive HPLC purification steps. The isolation process was monitored with MRGPRX2 transfected HEK 293 cells. The isolated peptides were sequenced by MS and synthetized. The synthetic peptides were used to determine degranulation of the human LAD 2 mast cell line by measuring ß-hexosaminidase release. RESULTS: Three endogenous MRGPRX2 activating peptides were isolated from human plasma. These peptides are identified as fragments of albumin. The isolated fragments activate MRGPRX2 and degranulate MRGPRX2 expressing LAD 2 cells in dose-dependent manner. CONCLUSIONS: The isolated basic peptides generated from human albumin are able to degranulate mast cells via the MRGPRX2. GENERAL SIGNIFICANCE: These endogenous albumin fragments, cleaved from albumin by mast cell secreted proteases, provide a possible pathway for self-perpetuating mast cell dependent inflammation.
Subject(s)
Immunoglobulin E/metabolism , Nerve Tissue Proteins/metabolism , Peptides/blood , Receptors, G-Protein-Coupled/metabolism , Receptors, Neuropeptide/metabolism , Serum Albumin, Human/metabolism , Cell Degranulation/genetics , Cell Degranulation/immunology , HEK293 Cells , Humans , Immunoglobulin E/immunology , Ligands , Mast Cells/immunology , Mast Cells/metabolism , Nerve Tissue Proteins/immunology , Peptide Library , Peptides/immunology , Receptors, G-Protein-Coupled/immunology , Receptors, Neuropeptide/immunology , Serum Albumin, Human/immunology , Signal Transduction , beta-N-Acetylhexosaminidases/metabolismABSTRACT
Galanin, one of the many (> 100) neuropeptides, was discovered in 1983 based on its C-terminal amidation motif. Over the years, three more members of the galanin family have been identified, and three galanin receptors have been cloned. Work in many laboratories has provided evidence that this peptide can act as a transmitter, modulator, and growth factor and that it is involved in a number of, especially, disease-related processes. In this introduction, we provide some historical aspects on the galanin research and how the field has developed over three decades.
Subject(s)
Galanin/physiology , Galanin/chemistry , Galanin/metabolism , Receptors, Galanin/metabolismABSTRACT
To clarify tissue-specificity of pancreatic beta cells, comparison of mRNA expression in various conditions of the tissue of multiple organisms is important. Although the developed methodologies for mRNA monitoring such as microarray, rely on the growth of dbEST (database of expressed sequence tag), a large number of unknown genes in the genome, especially in the rat, have not been shown to be expressed. In this study, we have established the first database of ESTs from rat pancreatic islet and RINm5F cells. Two cDNA libraries were constructed using mRNAs from rat pancreatic islet and RINm5F cells to cover a wider spectrum of expressed genes. Over 40,000 clones were randomly selected from the two libraries and partially sequenced. The sequences obtained were subjected to BLAST database analyses. This large-scale sequencing generated 40,710 3'-ESTs. Clustering analysis and homology search of nucleotide and peptide databases using both 3'- and 5'-ESTs revealed 10,406 non-redundant transcripts representing 4078 known genes or homologs and 6328 unknown genes. To confirm actual expression, the unknown sequences were further subjected to dbEST search, resulting in the identification of 5432 significant matches to those from other sources. Interestingly, of the remaining sequences showing no match, 779 were found to be encoded by exon-intron organization in the corresponding genomic sequences, suggesting that these are newly found as actually expressed in this study. Since many genes are up- or down-regulated in differing conditions, applications of the expression profile should facilitate identification of the genes involved in cell-specific functions in normal and disease states.
Subject(s)
Gene Expression Profiling , Islets of Langerhans/metabolism , Animals , Cell Line , DNA, Complementary/genetics , Databases, Genetic , Expressed Sequence Tags , Male , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, WistarABSTRACT
Apelin is an endogenous ligand of the human orphan receptor APJ. We detected apelin-like immunoreactivity in the adipocytes, gastric mucosa, and Kupffer cells in the liver. We also detected apelin-like immunoreactivity localized within the endothelia of small arteries in various organs. Further, it was found that mean arterial pressure after the administration of apelin-12, apelin-13, and apelin-36 at a dose of 10 nmol/kg in anaesthetized rats was reduced by 26+/-5, 11+/-4, and 5+/-4 mm Hg, respectively. In the presence of a nitric oxide (NO) synthase inhibitor, the effect of apelin-12 on blood pressure was abolished. Furthermore, the administration of apelin-12 (10 nmol/kg) in rats produced a transitory elevation of the plasma nitrite/nitrate concentration from a basal level of 21.4+/-1.6 to 27.0+/-1.5 microM. Thus, apelin may lower blood pressure via a nitric oxide-dependent mechanism.
Subject(s)
Antihypertensive Agents/administration & dosage , Blood Pressure/drug effects , Carrier Proteins/physiology , Nitric Oxide/physiology , Peptides/physiology , Receptors, G-Protein-Coupled , Animals , Antihypertensive Agents/chemical synthesis , Apelin , Apelin Receptors , Carrier Proteins/administration & dosage , Carrier Proteins/chemical synthesis , Enzyme Inhibitors/administration & dosage , Enzyme Inhibitors/pharmacology , In Vitro Techniques , Injections, Intraperitoneal , Injections, Intravenous , Intercellular Signaling Peptides and Proteins , Ligands , Male , NG-Nitroarginine Methyl Ester/administration & dosage , NG-Nitroarginine Methyl Ester/pharmacology , Nitrates/blood , Nitric Oxide/blood , Nitric Oxide Synthase/antagonists & inhibitors , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type III , Nitrites/blood , Organ Specificity , Peptides/administration & dosage , Peptides/chemical synthesis , Rats , Rats, Wistar , Receptors, Dopamine D2/metabolismABSTRACT
Natus-ALGO 2e, an automated ABR screener(Natus Medical, Foster City, CA, USA), compares the V wave of ABR evoked by 35-dB-nHL click stimuli by using a template-matching detection algorithm that provides only a pass-refer outcome. The aim of this study was to compare Natus-ALGO 2e with conventional ABR, and to evaluate its usefulness. The Natus-ALGO 2e screener was used to screen 202 ears of 101 neonates in our neonatal intensive care unit. The mean conceptional age at the time of screening was 40.4 +/- 3.0 weeks. 60 ears of 30 infants at high-risk of hearing impairment, including "refer" infants, were tested by the Natus-ALGO 2e and conventional ABR methods, and the results were compared. All neonates were tested with the Natus-ALGO 2e screener in a state of natural sleep, and screening time averaged 2 minutes 58 seconds. There were 97 cases in which both ears were passed, 3 cases in which both ears were referred, and one case in which one ear was referred. In comparison with conventional ABR, 53 of the 60 ears of 30 high-risk infants passed by the Natus-ALGO 2e method, whereas 14 of the 53 ears initially failed the conventional ABR screening. Of these 14 ears disagreements (the results of the Natus-ALGO 2e method passed, but the results of the conventional ABR failed), the results of the ABR screening changed to normal in 11 ears, and ABR showed improved threshold and latency in the other 3 ears after 5 weeks to 12 months. Among those that passed the Natus-ALGO 2e screening, the number of sweeps that failed the ABR screen was significantly greater than with normal ABR. Of the 7 ears of 4 patients that were referred on the basis of the Natus-ALGO 2e screening and failed by the conventional ABR method, 3 ears screened by the ABR method were normal when retested, and one ear passed by the Natus-ALGO 2e screening 12 weeks to 11 months later. In conclusion, Natus-ALGO 2e is useful for screening infant hearing because it can be performed quickly while the patient is sleeping naturally. In infants at high-risk for hearing impairment, the results of Natus-ALGO 2e and conventional ABR screening conflicted in numerous sweeps. Therefore, when there are many sweeps in high-risk infants, a retest should be performed that includes conventional ABR, even if they passed with Natus-ALGO 2e.
Subject(s)
Audiometry, Evoked Response/instrumentation , Neonatal Screening/instrumentation , Evoked Potentials, Auditory, Brain Stem , Hearing Disorders/congenital , Hearing Disorders/diagnosis , Humans , Infant, Newborn , Intensive Care Units, Neonatal , Neonatal Screening/methodsABSTRACT
The orphan G protein-coupled receptor APJ has been shown to be a coreceptor for human and simian immunodeficiency virus (HIV and SIV) strains. We have determined that some HIV and SIV strains use APJ as a coreceptor to infect the brain-derived NP-2/CD4 cells. Because apelin is an endogenous ligand for the APJ receptor, we examined the inhibitory effects of apelin peptides on HIV infection, and found that the apelin peptides inhibit the entry of some HIV-1 and HIV-2 into the NP-2/CD4 cells expressing APJ. The inhibitory efficiency has been found to be in the order of apelin-36>apelin-17>apelin-13>apelin-12.
Subject(s)
Carrier Proteins/pharmacology , HIV-1/drug effects , HIV-1/physiology , HIV-2/drug effects , HIV-2/physiology , Peptide Fragments/pharmacology , Receptors, G-Protein-Coupled , Amino Acid Sequence , Apelin , Apelin Receptors , Brain , CD4 Antigens/metabolism , Carrier Proteins/chemistry , Carrier Proteins/metabolism , Chemokines/pharmacology , Giant Cells/metabolism , Giant Cells/pathology , Giant Cells/virology , Glioma/metabolism , Glioma/pathology , Glioma/virology , HIV Reverse Transcriptase/metabolism , HIV-1/enzymology , HIV-1/metabolism , HIV-2/enzymology , HIV-2/metabolism , Humans , Inhibitory Concentration 50 , Intercellular Signaling Peptides and Proteins , Ligands , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Peptide Fragments/metabolism , RNA-Directed DNA Polymerase/metabolism , Receptors, CCR5/genetics , Receptors, CCR5/metabolism , Receptors, CXCR4/genetics , Receptors, CXCR4/metabolism , Receptors, Dopamine D2/genetics , Receptors, Dopamine D2/metabolism , Receptors, Virus/genetics , Receptors, Virus/metabolism , Simian Immunodeficiency Virus/enzymology , Simian Immunodeficiency Virus/metabolism , Simian Immunodeficiency Virus/physiology , Tumor Cells, CulturedABSTRACT
In the search for an endogenous ligand of the human orphan receptor APJ, we have isolated from bovine stomach extracts a novel 36-amino acid peptide, designated apelin. The APJ receptor is one of the G protein-coupled orphan receptors, many of which have been considered to be specific receptors for unidentified hormones and neuropeptides. We recently found the presence of apelin in the adipocytes and vascular walls as well as in the stomach. We examined biological activities of apelin and found that apelin lowered blood pressure in rats and also released cholecystokinin(CCK) from dispersed intestinal endocrine cells. Since apelin is an endogenous ligand for the HIV entry coreceptor APJ, we tested the effect of apelin on the entry of HIV in association with CD4, and found that apelin blocked the entry of HIV-1 and HIV-2.
Subject(s)
Carrier Proteins , GTP-Binding Proteins/metabolism , Receptors, Cell Surface/metabolism , Amino Acid Sequence , Animals , Anti-HIV Agents , Antihypertensive Agents , Apelin , Carrier Proteins/physiology , Cattle , Cholecystokinin/metabolism , Humans , Intercellular Signaling Peptides and Proteins , Ligands , Molecular Sequence Data , RatsABSTRACT
By using a strategy that we have developed to search for the ligands of orphan seven-transmembrane-domain receptors [S. Hinuma et al., Nature 393 (1998) 272-276], we have recently identified a natural ligand, apelin, for the orphan 7TMR, APJ [K. Tatemoto et al., Biochem. Biophys. Res. Commun. 251 (1998) 471-476]. In this paper, we isolated rat and mouse apelin cDNAs, and analyzed the tissue distribution of apelin mRNA in rats. Although apelin mRNA was widely detected in a variety of tissues, the highest expression of apelin mRNA was detected in the mammary gland of pregnant rats. In the mammary gland, biologically active apelin and its mRNA considerably increased during pregnancy and lactation, and reached a maximal level around parturition. Moreover, a large amount of apelin (14-93 pmol/ml) was found to be secreted in the bovine colostrum, and it was still detectable even in commercial bovine milk. Since apelin partially suppressed cytokine production by mouse spleen cells in response to T cell receptor/CD3 cross-linking, the oral intake of apelin in the colostrum and milk might modulate immune responses in neonates.
Subject(s)
Carrier Proteins/metabolism , Colostrum/metabolism , Receptors, G-Protein-Coupled , Adipokines , Amino Acid Sequence , Animals , Apelin , Apelin Receptors , CHO Cells , Carrier Proteins/chemical synthesis , Carrier Proteins/genetics , Cattle , Colforsin , Cricetinae , Cyclic AMP/metabolism , DNA, Complementary/isolation & purification , Female , Intercellular Signaling Peptides and Proteins , Lactation/metabolism , Ligands , Male , Mammary Glands, Animal/metabolism , Mice , Milk/chemistry , Molecular Sequence Data , Pregnancy/metabolism , RNA, Messenger/analysis , Rats , Rats, Wistar , Receptors, Dopamine D2/chemistry , Receptors, Dopamine D2/metabolism , Reverse Transcriptase Polymerase Chain ReactionABSTRACT
Uric acid values in serum have been analyzed as one of the markers to predict cellular damage due to ischemia reperfusion injury in the field of organ transplantation. The present study was conducted to confirm that uric acid values in serum could be an efficient marker of ischemic injury of liver parenchyma following hepatic vascular occlusion in human liver surgery. The changes in serum uric acid values were analyzed at fixed intervals during different liver surgeries. Significant increases in serum uric acid values were observed in patients who received the Pringle's maneuver in which hepatic vascular inflow was manipulated with a repetition of 15 min occlusion and 5 min perfusion, whereas almost no changes in uric acid values were found in both groups of patients who received the hemilobal occlusion of the Glisson's triad in which the right or left vessels were manipulated with a repetition of 30 min occlusion and 5 min perfusion and the "control method" in which the hepatic vessels of the lesion side were previously cut before liver resection. Uric acid values in serum increased in patients of Pringle's maneuver compared to those of the hemilobal occlusion of the Glisson's triad and the control method though these procedures were used in larger hepatectomies rather than Pringle's maneuver. The results indicated that serum uric acid values do not always reflect the severity of ischemia of the liver parenchyma but reflect intestinal congestion because marked intestinal congestion was observed in patients of Pringle's maneuver but not in patients of the hemilobal occlusion of the Glisson's triad and the control method. The evaluation of the severity of the ischemic injury of the liver should be done with caution when uric acid is used as a marker in human liver surgery.
Subject(s)
Hepatectomy/adverse effects , Intraoperative Complications/diagnosis , Liver Circulation , Liver Neoplasms/surgery , Liver/surgery , Reperfusion Injury/diagnosis , Uric Acid/blood , Adolescent , Adult , Aged , Biomarkers/blood , Child , Female , Humans , Intraoperative Complications/blood , Liver/blood supply , Living Donors , Male , Middle Aged , Monitoring, Intraoperative , Reperfusion Injury/bloodABSTRACT
In the search for an endogenous ligand of the orphan G protein-coupled receptor APJ, the presence of the ligand in various tissue extracts was examined by measuring the increase in extracellular acidification rate of the cells expressing the APJ receptor as a specific signal induced by the interaction of the receptor and ligand. By monitoring this activity, we isolated an APJ receptor ligand, designated apelin, from bovine stomach extracts. The structures of bovine and human apelin preproproteins were deduced from the sequences of the corresponding cDNAs. The preproproteins consisted of 77 amino acid residues, and the apelin sequence was encoded in the C-terminal regions. Synthetic peptides derived from the C-terminal amino acid sequence of bovine preproapelin were capable of specifically promoting the acidification rate in the cells expressing the APJ receptor in a range from 10(-7) to 10(-10) M, indicating that apelin is an endogenous ligand for the APJ receptor.
Subject(s)
Carrier Proteins/metabolism , Gastric Mucosa/metabolism , Receptors, Dopamine D2/metabolism , Receptors, G-Protein-Coupled , Amino Acid Sequence , Amygdala/metabolism , Animals , Apelin , Apelin Receptors , Base Sequence , CHO Cells , Carrier Proteins/chemistry , Carrier Proteins/genetics , Cattle , Cloning, Molecular , Cricetinae , GTP-Binding Proteins/metabolism , Humans , Intercellular Signaling Peptides and Proteins , Ligands , Lung/metabolism , Molecular Sequence Data , Peptide Fragments/chemical synthesis , Peptide Fragments/chemistry , Peptide Fragments/metabolism , Polymerase Chain Reaction , Protein Precursors/chemistry , Protein Precursors/metabolism , Receptors, Dopamine D2/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Sequence Alignment , Sequence Homology, Amino Acid , Tissue Extracts/chemistry , Tissue Extracts/metabolism , TransfectionABSTRACT
Diazepam binding inhibitor (DBI1-86) has recently been isolated in search for a cholecystokinin (CCK)-releasing peptide in the duodenum that is responsible for the feedback regulation of exocrine pancreatic secretion. Synthetic porcine DBI1-86 stimulates CCK release in vivo and in vitro from isolated intestinal mucosal cells. We postulated that DBI intraduodenally releases CCK in a paracrine fashion and might be the missing link in the feedback regulation of exocrine pancreatic secretion. Somatostatin, peptide YY (PYY) and taurocholate are known to inhibit feedback-stimulated CCK release in the rat. In this study, we investigated the effect of somatostatin, PYY and taurocholate on DBI-stimulated CCK secretion. Dispersed rat intestinal mucosal cells were prepared from the proximal small bowel and continuously perfused. The perfusate was collected and the release of CCK into the medium was measured. DBI1-86 dose-dependently stimulated CCK release, with a maximal effect at 10(-9) M. Somatostatin blocked the DBI-stimulated CCK release. Pretreatment of the cells with pertussis toxin fully reversed the inhibitory effect of somatostatin on DBI-stimulated CCK secretion, suggesting that somatostatin exerts its action by an inhibitory G-protein. In contrast, PYY (10(-6) M) and taurocholate (10(-6) M) did not affect DBI stimulated CCK levels, indicating that they act through different mechanisms to inhibit feedback-stimulated CCK release.
Subject(s)
Carrier Proteins/metabolism , Cholecystokinin/metabolism , Somatostatin/metabolism , Taurocholic Acid/metabolism , Animals , Carrier Proteins/pharmacology , Diazepam Binding Inhibitor , GTP-Binding Proteins/metabolism , Hormones/metabolism , Male , Peptide YY/pharmacology , Rabbits , Rats , Rats, Sprague-Dawley , Somatostatin/pharmacology , Taurocholic Acid/pharmacologyABSTRACT
When cells dissociated from the neonatal rat brains are plated on a poly-lysine-coated surface in a serum-free medium, they display a strange morphology: a dark and extended cell body. Preincubation of the surface with fetal bovine serum was found to inhibit the appearance of this strange contraction of the basal cell sheets in a dose-dependent manner. This finding indicated the presence of a factor(s) in the serum, which might be an appropriate substratum for prolonged survival of brain neurons. In the current study, this factor was highly purified through DEAE ion-exchange chromatography followed by gel filtration. The factor was eluted from a Superose column at fractions corresponding to a molecular weight greater than 1000 kDa. By SDS-PAGE analysis, these fractions were found to contain a major band (>/=1000 kDa) positive for alcian blue and few minor bands faintly stainable with Coomassie blue. The activity of the purified sample, inducing the morphological change in cells, was diminished by incubation with chondroitinase ABC. Neither heparitinase II, hyaluronidase, nor trypsin modified the activity. An authentic chondroitin sulfate (type B) mimicked the serum action on the morphology of brain cells in early stages of culture. Taking these findings together, it is suggested that the factor in serum beneficial for the attachment of brain cells is composed of a chondroitin sulfate with a Mr greater than 1000 kDa. Cortical cells dissociated from the neonatal rat brain attached well to the purified factor-coated surface and displayed a healthy morphology: an optically-reflective cell body with thick neurites for at least 3 days in the absence of serum.
Subject(s)
Cerebral Cortex/cytology , Chondroitin Sulfates/blood , Neurons/cytology , Animals , Animals, Newborn , Cattle , Cell Culture Techniques/methods , Cells, Cultured , Chondroitin Sulfates/isolation & purification , Chondroitin Sulfates/pharmacology , Chromatography, DEAE-Cellulose , Chromatography, Gel , Culture Media , Culture Media, Serum-Free , Electrophoresis, Polyacrylamide Gel , Neurons/drug effects , RatsABSTRACT
The diabetes or impaired glucose tolerance that occurs in most patients with pancreatic cancer is characterized by profound insulin resistance. Recent evidence suggests that the diabetes may result from the presence of the tumor rather than being a predisposing factor to development of the malignancy. Some islet hormones have been shown to exhibit diabetogenic effects. To investigate the potential role of these hormones in the diabetic state associated with pancreatic cancer, we measured islet hormones during fasting in pancreatic cancer patients (n = 30), patients with other malignancies (n = 43), and healthy controls (n = 25). Preoperative pancreatic cancer patients were classified as normal glucose tolerance (NGTT), impaired glucose tolerance (IGTT), non-insulin-requiring diabetes (NIRD), and insulin-requiring diabetes (IRD). Nine pancreatic cancer patients were studied after tumor removal by subtotal pancreatectomy. Some preoperative pancreatic cancer patients (n = 19), postoperative patients (n = 9), and controls (n = 8) were also studied during hyperglycemia and following glucagon injection. Fasting plasma C-peptide was elevated in NIRD pancreatic cancer patients compared to controls. Fasting levels of islet amyloid polypeptide (IAPP), glucagon, and somatostatin were elevated in NIRD and IRD patients. IAPP and glucagon, but not somatostatin, normalized following subtotal pancreatectomy. During hyperglycemia, increases in C-peptide and IAPP were seen only in controls and in NGTT and postoperative pancreatic cancer patients. After glucagon infusion, IAPP levels increased in controls and nondiabetic cancer patients; C-peptide levels increased in controls, nondiabetic patients, and NIRD. Responses of C-peptide and IAPP to glucagon normalized after pancreatectomy. During hyperglycemia, glucagon levels fell in all groups except IGTT patients and a decrease in somatostatin concentrations was seen in controls.
Subject(s)
Adenocarcinoma/metabolism , Diabetes Mellitus/metabolism , Islets of Langerhans/metabolism , Pancreatic Hormones/metabolism , Pancreatic Neoplasms/metabolism , Adenocarcinoma/complications , Aged , Diabetes Complications , Fasting , Female , Glucagon/pharmacology , Glucose Clamp Technique , Glucose Tolerance Test , Humans , Hyperglycemia/metabolism , Islets of Langerhans/drug effects , Male , Middle Aged , Pancreatic Hormones/blood , Pancreatic Neoplasms/complicationsABSTRACT
We examined the electrophysiological effect of pituitary adenylate cyclase activating polypeptide (PACAP) in isolated Xenopus laevis oocytes in vitro. In conventional two-electrode voltage clamp experiments, PACAP (1-10 microM) activated an inward rectifier current at membrane potentials more negative than -60 mV without causing any significant change in currents at potentials more positive than -60 mV both in the follicle-enclosed oocyte and in the defolliculated oocyte. This current reversed at -22.5 mV, close to the theoretical value of Cl- equilibrium potential and the reversal potential of this current was shifted positively by reducing [Cl-]o. This current was blocked by Cl- channel blocker SITS and Ba2+. Furthermore, VIP and adenylate cyclase activator forskolin did not elicit the currents. In conclusion, PACAP elicited the hyperpolarization-activated Cl- current in Xenopus laevis oocytes. This current may modulate the membrane potential of the oocyte, thereby affecting the oocyte physiology.
Subject(s)
Chloride Channels/drug effects , Chloride Channels/physiology , Neuropeptides/pharmacology , Oocytes/drug effects , Oocytes/physiology , Animals , Chloride Channels/metabolism , Female , Membrane Potentials/drug effects , Oocytes/metabolism , Ovarian Follicle/drug effects , Ovarian Follicle/physiology , Patch-Clamp Techniques , Pituitary Adenylate Cyclase-Activating Polypeptide , Receptors, Somatotropin/drug effects , Receptors, Vasoactive Intestinal Peptide/drug effects , Vasoactive Intestinal Peptide/pharmacology , Xenopus Proteins , Xenopus laevisABSTRACT
The present study was conducted to develop an efficient marker which can evaluate the influence of the occlusion of hepatic vascular inflow, which technique is commonly used in major liver surgery or in liver transplantation. Serum samples from the rats induced by hepatic vascular inflow occlusion were analyzed with high performance liquid chromatography with the electrochemical detection, and a substance which changed in accordance with the duration of the occlusion was obtained. Both the retention time and the ultraviolet absorption spectra of the substance completely agreed with those of an authentic uric acid and the substance was ultimately determined to be uric acid. To evaluate the changes in serum uric acid during different forms of hepatic vascular inflow occlusion we devised the four types of experimental model, viz. the occlusion of hepatic artery, portal vein, both hepatic artery and portal vein and both hepatic artery and portal vein of left hepatic lobes. From the device of experiments our results indicated that in the early stage of hepatic vascular inflow occlusion the high values of serum uric acid did not reflect the damage of hepatic circulation but rather responded to the intestinal congestion. Our results also indicated that even after the declamping of hepatic vascular inflow if high values of serum uric acid are prolonged it means the deterioration of the portocaval circulation including both intestinal and hepatic circulation. So that the evaluation of the severity of injured liver due to hepatic vascular inflow occlusion should be done with the caution especially in vivo study when uric acid values are used as a marker.
Subject(s)
Arterial Occlusive Diseases/blood , Liver/blood supply , Uric Acid/blood , Animals , Arterial Occlusive Diseases/physiopathology , Aspartate Aminotransferases/blood , Biomarkers/blood , Blood Pressure/physiology , Chromatography, High Pressure Liquid , Hematocrit , Liver Circulation/physiology , Male , Rats , Rats, WistarABSTRACT
To extrapolate the function of the leptomeninges, we examined the profile of the proteins secreted from the cultured leptomeningeal cells prepared from 1-2-day-old rats. In sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the medium conditioned with the cultured cells, 20-25 differentially distinctive protein bands were noted. Through several chromatographic procedures (Sephadex G-75, Mono Q, and 7C8-300), altogether 18 proteins were purified to homogeneity, and the partial amino acid sequence of each protein was determined. Homology search revealed that the major proteins included prostaglandin-D-synthase or beta-trace protein, insulin-like growth factor (IGF)-II, IGF-binding protein-2, apolipoprotein E, beta 2-microglobulin, cystatin C, transferrin, peptidyl-prolyl cis-trans isomerase or cyclophilin C, secreted protein acidic and rich in cysteine, ubiquitin, lysozyme C, extracellular superoxide dismutase, and collagen alpha-1 (III). Most of these proteins are known to be the major brain-derived protein constituents of CSF and are thought to play important roles in certain biological events in the brain. Considering the morphological features, the present findings suggest the importance of the leptomeninges as an origin of such proteins in CSF.